rt112 cell line (DSMZ)
Structured Review

Rt112 Cell Line, supplied by DSMZ, used in various techniques. Bioz Stars score: 95/100, based on 156 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rt112+cells/RT-112/bio_rxiv__2025__09__30__679440-176-0-6
Average 95 stars, based on 156 article reviews
Images
1) Product Images from "CAR T cells targeting Nectin-4 safely overcome resistance to anti-Nectin-4 antibody-drug conjugate in solid tumors"
Article Title: CAR T cells targeting Nectin-4 safely overcome resistance to anti-Nectin-4 antibody-drug conjugate in solid tumors
Journal: bioRxiv
doi: 10.1101/2025.09.30.679440
Figure Legend Snippet: A. Nectin-4 expression on three cell lines in comparison with SUM190PT. B. MCF7, HT29, RT112 and SUM190PT cell lines were treated with CD30-MMAE(negative control) and enfortumab vedotin. MCF7, HT29 and RT112 cell lines are resistant to enfortumab vedotin whereas SUM190PT is sensible. n = 2 biologic replicates were examined in one experiment. C . 4-hour caspase 3/7 cytotoxicity assay indicating a tumor killing of CARTN4 cells against MCF7, HT29, RT112. n=4 healthy donors were examined in three independent experiments. Data in panels B, and C are presented as Mean +/- SEM. P-values were calculated using a 2way ANOVA. Source data are provided in the Source Data file.
Techniques Used: Expressing, Comparison, Negative Control, Cytotoxicity Assay
Related Articles
Cell Culture:Article Title: The mycotoxin viriditoxin induces leukemia- and lymphoma-specific apoptosis by targeting mitochondrial metabolism. Article Snippet: .. Cell Death and Disease (2022) 13:938 Cell lines, primary cells, and cell culture DG75 cells (human B cell Burkitt lymphoma; #ACC-83), HeLa cells (human cervix carcinoma; #ACC-57), HT29 cells (human colon carcinoma; #ACC-299), HCT116 cells (human colon carcinoma; #ACC-581), Jurkat (JM) cells (human T cell acute lymphoblastic leukemia; #ACC-282), MCF7 cells (human breast carcinoma; #ACC-115), other:Article Title: The Secretome Engages STAT3 to Favor a Cytokine-rich Microenvironment in Mediating Acquired Resistance to FGFR Inhibitors. Article Snippet: 2 Acquired resistance severely hinders the application of small molecule inhibitors.. Our understanding of acquired resistance related to fibroblast growth factor receptors (FGFRs) is limited.. Here, to explore the underlying mechanism of acquired resistance in FGFR-aberrant cancer cells, we generated cells resistant to multiple FGFR inhibitors and investigated the potential mechanisms underlying acquired resistance. Article Title: Preclinical evaluation of 3D185, a novel potent inhibitor of FGFR1/2/3 and CSF-1R, in FGFR-dependent and macrophage-dominant cancer models Article Snippet: Article Title: c-Myc Alteration Determines the Therapeutic Response to FGFR Inhibitors Article Snippet: c-Myc alteration determines the therapeutic response to FGFR inhibitors Hongyan Liu, Jing Ai, Aijun Shen, Yi Chen, Xinyi Wang, Xia Peng, Hui Chen, Yanyan Shen, Min Huang*, Jian Ding*, Meiyu Geng* Author affiliations: Division of Anti-tumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, P.R.. China. Knockdown:Article Title: The small conductance calcium-activated potassium channel 3 (SK3) is a molecular target for Edelfosine to reduce the invasive potential of urothelial carcinoma cells. Article Snippet: Metastasis is the survival-determining factor in urothelial carcinoma (UC) of the urinary bladder.. The small conductance calcium-activated potassium channel 3 (SK3) enhances tumor cell invasion in breast cancer and malignant melanoma.. Since Edelfosine, a glycerophospholipid with antitumoral properties, effectively inhibits SK3 channel activity, our goal was to evaluate SK3 as a potential molecular target to inhibit the gain of an invasive phenotype in UC. Migration:Article Title: The small conductance calcium-activated potassium channel 3 (SK3) is a molecular target for Edelfosine to reduce the invasive potential of urothelial carcinoma cells. Article Snippet: Metastasis is the survival-determining factor in urothelial carcinoma (UC) of the urinary bladder.. The small conductance calcium-activated potassium channel 3 (SK3) enhances tumor cell invasion in breast cancer and malignant melanoma.. Since Edelfosine, a glycerophospholipid with antitumoral properties, effectively inhibits SK3 channel activity, our goal was to evaluate SK3 as a potential molecular target to inhibit the gain of an invasive phenotype in UC. Control:Article Title: The small conductance calcium-activated potassium channel 3 (SK3) is a molecular target for Edelfosine to reduce the invasive potential of urothelial carcinoma cells. Article Snippet: Metastasis is the survival-determining factor in urothelial carcinoma (UC) of the urinary bladder.. The small conductance calcium-activated potassium channel 3 (SK3) enhances tumor cell invasion in breast cancer and malignant melanoma.. Since Edelfosine, a glycerophospholipid with antitumoral properties, effectively inhibits SK3 channel activity, our goal was to evaluate SK3 as a potential molecular target to inhibit the gain of an invasive phenotype in UC. Boyden Chamber Assay:Article Title: The small conductance calcium-activated potassium channel 3 (SK3) is a molecular target for Edelfosine to reduce the invasive potential of urothelial carcinoma cells. Article Snippet: Metastasis is the survival-determining factor in urothelial carcinoma (UC) of the urinary bladder.. The small conductance calcium-activated potassium channel 3 (SK3) enhances tumor cell invasion in breast cancer and malignant melanoma.. Since Edelfosine, a glycerophospholipid with antitumoral properties, effectively inhibits SK3 channel activity, our goal was to evaluate SK3 as a potential molecular target to inhibit the gain of an invasive phenotype in UC. |
